Bupropion, originally named Amfebutamone, sold under the brand name Wellbutrin, is a medication commonly prescribed for the treatment of major depressive disorder (MDD), as is often used off-label for attention deficit hyperactivity disorder (ADHD), anxiety, obesity, and bipolar disorder. While it has demonstrated efficacy in addressing certain mental health issues, it is essential to examine the potential harms associated with its use, particularly considering its modulation of neurotransmitters like norepinephrine (NE) and dopamine. This article aims to shed light on the risks of Wellbutrin use, with a focus on its implications for pregnant or lactating women. Additionally, we'll explore the idea that the indications for Wellbutrin may stem from underlying nutrition and lifestyle factors rather than a deficiency of the medication.

As of 2021, Bupropion, maintained its position as the 18th most prescribed drug in the United States. With an estimated 29,099,445 prescriptions filled, it remains a widely utilized medication in the realm of psychiatric pharmaceuticals. This notable figure underscores the prevalence of its use in addressing various conditions, including depression and smoking cessation.

The estimated number of patients in the United States receiving Bupropion in 2021 reached 6,412,363. This statistic reflects the significant impact and reach of Bupropion across diverse patient populations. Its popularity could be attributed to its purported effectiveness in managing depressive disorders, ADHD, anxiety, and aiding individuals in smoking cessation efforts.

Wellbutrin functions by influencing the levels of neurotransmitters in the brain, primarily inhibiting the breakdown of norepinephrine and dopamine. While this mechanism contributes to its antidepressant effects, it also raises concerns about potential side effects and risks. Altering neurotransmitter levels can lead to a range of adverse effects, with the most common including:

• anxiety
• dry mouth
• hyperventilation
• irregular heartbeats
• irritability
• restlessness
• shaking
• trouble sleeping

Here are some of the possible harms and common side effects associated with Wellbutrin:

1. Insomnia: Difficulty sleeping is a frequently reported side effect.
2. Dry Mouth: Many users experience a persistent dry mouth.
3. Headache: Headaches are a common complaint.
4. Nausea and Vomiting: Some people may feel nauseous or vomit.
5. Constipation: Gastrointestinal issues, such as constipation, are possible.
6. Dizziness: Users may experience dizziness or lightheadedness.
7. Weight Loss: Appetite suppression can lead to weight loss.
8. Increased Sweating: Excessive sweating is another potential side effect.

Serious Side Effects

1. Seizures: Wellbutrin can increase the risk of seizures, especially at higher doses.
2. Hypertension: Elevated blood pressure has been reported.
3. Mania: In some cases, Wellbutrin can trigger manic episodes in individuals with bipolar disorder.
4. Psychiatric Symptoms: Agitation, anxiety, and psychosis have been observed.
5. Liver Damage: Although rare, Wellbutrin can cause liver injury.

Allergic Reactions

1. Rash and Itching: Skin reactions such as rashes and itching can occur.
2. Swelling: Swelling of the face, lips, tongue, or throat can indicate a severe allergic reaction.
3. Difficulty Breathing: Respiratory issues are a severe sign of an allergic reaction.

Cardiovascular Effects

1. Palpitations: Users may experience an irregular heartbeat or palpitations.
2. Increased Heart Rate: Tachycardia, or an increased heart rate, can occur.

Psychiatric Risks

1. Suicidal Thoughts and Behaviors: Like other antidepressants, Wellbutrin carries a risk of increased suicidal thoughts and behaviors, especially in young adults and adolescents.

Other Considerations

1. Drug Interactions: Wellbutrin can interact with other medications, leading to adverse effects or reduced efficacy.
2. Use in Pregnancy and Breastfeeding: See Below. The safety of Wellbutrin during pregnancy and breastfeeding is not well established and should be discussed with a healthcare provider.

Long-Term Risks

1. Dependence and Withdrawal: Although less common, some users may develop dependence or experience withdrawal symptoms upon discontinuation.

While the approach of inhibiting the reuptake of dopamine and norepinephrine aims to enhance the availability of these neurotransmitters in the brain, an imbalance can lead to adverse effects. Excessive levels or prolonged elevated concentrations of these neurotransmitters may contribute to overstimulation and disrupt normal neural signaling.

Norepinephrine is a neurotransmitter involved in the body's "fight or flight" response, influencing heart rate and blood pressure. Medications that impact norepinephrine reuptake can lead to cardiovascular side effects, including increased heart rate and elevated blood pressure. Individuals with pre-existing cardiovascular conditions may be at a higher risk for complications.

Altered levels of dopamine and norepinephrine can influence mood and behavior. In some cases, inhibiting reuptake may contribute to psychiatric symptoms such as anxiety, restlessness, or irritability. Balancing the desired therapeutic effects with potential adverse psychological consequences is a delicate consideration.

Abruptly discontinuing medications that inhibit dopamine and norepinephrine reuptake can lead to withdrawal symptoms. These symptoms may include mood swings, fatigue, and cognitive disturbances. Additionally, some individuals may develop a dependence on these medications, requiring careful management to taper off gradually.

Dopamine and norepinephrine play roles in regulating sleep and appetite. Disrupting these neurotransmitters can lead to sleep disturbances, insomnia, or changes in appetite. Monitoring and addressing these side effects are crucial for maintaining overall well-being during the course of treatment.

The response to medications that inhibit dopamine and norepinephrine reuptake can vary widely among individuals. Factors such as genetic predispositions, existing medical conditions, and concurrent medications may influence how the body reacts to these interventions. Individualized treatment plans and close monitoring are essential components of responsible prescribing.​

Pregnancy and lactation introduce unique considerations when it comes to medication use. The use of Wellbutrin (bupropion) or any other medication during pregnancy requires careful consideration of potential risks and benefits. While studies on the safety of Wellbutrin during pregnancy are inconclusive, there is evidence suggesting a potential association with adverse outcomes, including preterm birth and low birth weight. Additionally, Wellbutrin and its metabolites are present in human breast milk excretions, raising concerns about its impact on nursing infants including alterations in neurotransmitters. Expectant or breastfeeding mothers should engage in thorough discussions with their healthcare providers to weigh the potential benefits against the risks and explore alternative treatment options.

Here are some considerations regarding the potential harms of taking Wellbutrin during pregnancy:

1. Risk of Birth Defects: Researchers have observed ​a potential association between the use of certain antidepressants, including Wellbutrin, during the first trimester of pregnancy and a slightly increased risk of certain birth defects. However, the absolute risk is generally low. In rabbits, increased incidences of fetal malformations and skeletal variations were observed at the lowest dose tested (25 mg per kg per day, approximately equal to the maximum recommended human dose on a mg per m2 basis) and greater. 
2. Neonatal Complications: Neonatal complications, such as withdrawal symptoms or adaptation issues, have been reported in infants born to mothers who took Wellbutrin during pregnancy. These symptoms are typically transient and managed by healthcare professionals.
3. Preterm Birth and Low Birth Weight: Researchers have observed a possible association between antidepressant use during pregnancy and an increased risk of preterm birth or low birth weight. In rabbits, decreased fetal weights were observed at 50 mg per kg and greater. However, the overall impact is modest, and the reasons for these associations are complex.
4. Persistent Pulmonary Hypertension of the Newborn (PPHN): There have been concerns about a potential link between maternal antidepressant use, including Wellbutrin, and an increased risk of PPHN. However, research results have been inconsistent, and the absolute risk remains low.

Wellbutrin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It's essential for individuals taking Wellbutrin and considering pregnancy, or those who become pregnant while on the medication, to discuss their situation with healthcare professionals. Abruptly stopping antidepressant medication can lead to a recurrence of depressive symptoms, which may have its own set of risks during pregnancy.

Healthcare providers will carefully weigh the potential risks and benefits based on the individual's mental health needs. In some cases, healthcare professionals may recommend continuing the medication, adjusting the dosage, or exploring alternative treatments.

Pregnant individuals should inform their healthcare providers about their medication use and work collaboratively to make informed decisions that prioritize both maternal mental health and the well-being of the developing fetus.

While the active ingredient in Wellbutrin plays a significant role in its pharmacological effects, it's important not to overlook the inactive ingredients in the formulation. While they make up a smaller portion of the overall product, their cumulative impact should not be underestimated, especially considering the frequent administration of the medication.

Though often considered inert, inactive ingredients can still interact with the body in various ways, potentially influencing drug absorption, metabolism, and overall therapeutic efficacy. Moreover, individual sensitivities or allergic reactions to certain inactive ingredients can occur, further emphasizing the importance of evaluating the entire list of components.
​
Even seemingly minor alterations in inactive ingredients can have profound implications, particularly when considering long-term usage. Over time, repeated exposure to these substances may contribute to cumulative effects or unexpected reactions. Therefore, comprehensive scrutiny of all ingredients, active and inactive alike, is essential for a thorough assessment of the safety profile of Wellbutrin and other pharmaceutical products.

The vibrant hues that adorn our favorite processed foods often come from artificial food colorings, but behind the visual appeal lies a potential risk, particularly for pregnant or lactating women. Artificial food color usually contains petroleum and is manufactured in a chemical process that includes formaldehyde, aniline, hydroxides, and sulfuric acids. Most impurities in the food color are in the form of salts or acids. Sometimes lead, arsenic, and mercury may be present as impurities. The U.S. FDA is yet to study the effects of synthetic dyes on behavior in children. 

To date, there are numerous scientific articles highlighting the relationship of consumption of food colorings to the following health conditions:

• Attention Deficit Hyperactivity Disorder
• Attention Deficit Disorder with Hyperactivity
• Hyperkinetic Syndrome
• Anaphylaxis
• Chemically-Induced Liver Damage
• Food Allergies
• Leukocytoclastic Vasculitis
• DNA damage
• Oxidative Stress
• Asthma
• Allergies
• Angioedema
• Excitotoxicity
• Neurodevelopmental Disorders
• Urticaria

Underlying these conditions are the documented mechanics of action that cause physiologic imbalance, which include:

• Cytotoxicity
• Hepatotoxicity
• Genotoxicity
• Mutagenicity
• Neurotoxicity

​Research has raised concerns about the consumption of food colorings and their potential adverse effects, including implications for conditions like ADHD, autism, and gastrointestinal dysfunction.

There is a substantial amount of data exploring the connection between artificial food colorings and ADHD. Researchers suggest that certain artificial colorings may exacerbate hyperactivity and inattention in children with ADHD. Pregnant women, mindful of their diet's impact on fetal development, may choose to limit the intake of foods containing these colorings.

The relationship between food colorings and autism spectrum disorders (and the underlying inflammation in the brain) is a topic of ongoing investigation. Meta-analysis have documented a link, emphasizing the need for caution, especially during pregnancy and lactation. As the developing brain is susceptible to external influences, limiting exposure to artificial additives becomes a consideration for expectant and nursing mothers.

Artificial food colorings have been associated with gastrointestinal disturbances, ranging from discomfort to more severe issues. Pregnant women, already navigating changes in digestion due to hormonal shifts, may choose to minimize exposure to food colorings to promote digestive well-being during this crucial period.

Potential Harms for Pregnant and Lactating Women:

1. Fetal Development: The developing fetus is particularly vulnerable to external influences. Limited research suggests that certain food colorings may cross the placental barrier, potentially impacting fetal development.
2. Breast Milk Composition: Lactating women should be mindful of their dietary choices, as food colorings have been detected in breast milk. While the significance of this transfer is still under investigation, cautious choices can contribute to ensuring the purity of breast milk.
3. Gastrointestinal Sensitivity: Pregnancy often brings about changes in digestion, and artificial food colorings may exacerbate gastrointestinal discomfort. Sensitivity to these additives varies, and pregnant women may choose to adopt a more natural and minimally processed diet.

For pregnant or lactating women concerned about the potential harms of food colorings, opting for a diet rich in whole, unprocessed foods becomes a valuable strategy. Choosing fruits, vegetables, and other naturally colorful sources can provide vibrant flavors without the need for artificial additives.

While the connection between food colorings and adverse health outcomes is an area of ongoing research, pregnant and lactating women may choose to err on the side of caution. Prioritizing a diet that minimizes artificial additives and focuses on nutrient-dense, whole foods is a proactive step toward supporting both maternal and fetal health. Always consult with healthcare professionals for personalized guidance based on individual circumstances and health considerations.

The concerns that arise with the safety of consuming PEG are multifold, including: 

1. Pollution: The process to produce polyethylene glycol requires a chemical reaction known as ethoxylation and the use of compounds known as ethylene oxide and 1,4-dioxane – two chemicals that have well-documented toxic effects on humans.
2. Contamination: PEGs are widely utilized for their ability to enhance penetration and absorption. But this also means that prolonged use or high doses of PEG can significantly enhance your body’s absorption of other toxins and harmful compounds that are found alongside PEGs or within the environment. 
3. Lack of studies: Because polyethylene glycol has numerous derivatives and molecular weights, extensive studies have only been conducted on a handful of different PEG compounds. There is limited information on the real impact of PEGs as a whole and more PEG toxicity research is needed to truly understand this compound’s effects on the human body.

Depending on manufacturing processes, PEGs may be contaminated with measurable amounts of ethylene oxide and 1,4-dioxane. The International Agency for Research on Cancer classifies ethylene oxide as a known human carcinogen and 1,4-dioxane as a possible human carcinogen. Ethylene oxide can also harm the nervous system and the California Environmental Protection Agency has classified it as a developmental toxicant based on evidence that it may interfere with human development. 

1,4-dioxane is also persistent. In other words, it doesn’t easily degrade and can remain in the environment long after it is rinsed down the shower drain. 1,4-dioxane can be removed from cosmetics during the manufacturing process by vacuum stripping, but there is no easy way for consumers to know whether products containing PEGs have undergone this process.In a study of personal care products marketed as “natural” or “organic” (uncertified), U.S. researchers found 1,4-dioxane as a contaminant in 46 of 100 products analyzed. 

While carcinogenic contaminants are the primary concern, PEG compounds themselves show some evidence of genotoxicity and if used on broken skin can cause irritation and systemic toxicity. PEG itself is classified as expected to be toxic or harmful as mentioned on the Environment Canada Domestic Substance List. The industry panel that reviews the safety of cosmetics ingredients concluded that some PEG compounds are not safe for use on damaged skin (although the assessment generally approved of the use of these chemicals in cosmetics). Also, PEG functions as a “penetration enhancer,” increasing the permeability of the skin to allow greater absorption of the ingredients — including harmful ingredients.

Researchers have observed that a large percentage of parents, caregivers, and practitioners described an explosion of neurological side effects seemingly correlated to polyethylene glycol administration. Those side effects include:

• Abnormal behavior
• Anger
• Anxiety 
• Mood swings
• Seizures
• Sensory disturbances

Commonly found in various products, such as medications, laxatives, and skincare items, PEG may lead to the following potential harms:

1. Gastrointestinal Issues: Oral ingestion of PEG, particularly in laxatives or medications, may cause gastrointestinal side effects such as bloating, cramps, gas, nausea, diarrhea, and vomiting.
2. Dehydration: Excessive use of PEG laxatives without adequate fluid intake can lead to dehydration. It's important to follow the recommended dosages and stay hydrated while using PEG-containing products.
3. Allergic Reactions: Although rare, some individuals may be allergic to PEG, leading to allergic reactions like rash, itching, swelling, or difficulty breathing. If any allergic symptoms occur, immediate medical attention is necessary.
4. Renal Impairment: PEG has been associated with cases of renal injury, particularly in individuals with pre-existing kidney conditions. People with kidney issues should use PEG-containing products cautiously under medical supervision.
5. Electrolyte Imbalance: Because of its ability to disrupt the flow of water, PEG laxatives can lead to electrolyte imbalances, which may result in abnormal levels of sodium, potassium, calcium, phosphate, and other electrolytes in the body. Severe electrolyte imbalances can have serious health consequences. Consumption of PEG has also been linked to an increased risk of metabolic acidosis, which is a build-up of acid and toxins in the body.
6. Systemic Absorption: While the systemic absorption of PEG from the gastrointestinal tract is generally low, excessive use or prolonged exposure may increase the risk of systemic absorption, potentially leading to adverse effects.
7. Hypersensitivity and Allergic Reactions: Individuals with a history of hypersensitivity to PEG or related compounds should avoid products containing PEG.  There are have been documented cases of an allergy to PEG. Some cases have even resulted in anaphylaxis – a severe and potentially life-threatening allergic reaction. Due to the risk of exposure to polyethylene glycol, the FDA has issued a warning to anyone with a known or suspected PEG allergy to communicate clearly with healthcare professionals as PEGs can be found lurking in medications, vaccines, contrast agents, and more. Researchers have estimated that approximately 72% of the US population has acquired anti PEG antibodies. The referenced study used blood samples taken from 1990-1999 and earlier, showing a steady increase over time in the percentage of those with antibodies to PEG, making it conservative to estimate, after two decades, that the incidence is closer to 80% today. 

People with pre-existing health conditions, especially those affecting the kidneys, should inform their healthcare providers before using PEG-containing products. As with any substance, individual responses to PEG can vary, and people experiencing adverse effects should seek medical attention promptly. It's important to weigh the risks and benefits of using PEG-based products based on individual health conditions and circumstances.

​Talc is a mineral commonly used in various products such as talcum powder, cosmetics, and personal care items. While talc is considered GRAS for external use, there have been concerns and controversies regarding potential health risks associated with its use, primarily when used in certain ways or in specific product formulations. Here are some of the concerns related to talc:

1. Contamination Concerns: Talc products have been found to be contaminated with substances like asbestos, which is a known carcinogen. While regulations and testing standards are in place to monitor and limit asbestos contamination in talc products, Johnson & Johnson, the maker of Johnson’s Baby Powder, is facing more than 9,000 plaintiffs in cases involving body powders with talc contaminated with asbestos.
2. Ovarian Cancer: There has been some controversy and litigation surrounding the potential link between talcum powder use in the genital area and an increased risk of ovarian cancer in women, due to contamination of asbestos. 
3. Respiratory Issues: Inhalation of talc powder (likely not a concern with the consumption of Wellbutrin), particularly in occupational settings such as talc mining or during certain industrial processes, may pose respiratory risks. Talc is closely related to asbestos, and in some natural deposits, talc may be contaminated with asbestos fibers, which are known respiratory hazards.
4. Pulmonary Effects in Infants: Although likely not a concern with the consumption of Wellbutrin, there have been reports of respiratory distress and other pulmonary issues in infants when talc-containing products, such as baby powders, are used excessively. Inhaling talc powder can be harmful to an infant's developing respiratory system.
5. Skin Irritation: Although likely not a concern with the consumption of Wellbutrin, in some individuals, talc may cause skin irritation or allergies. Redness, itching, or rash may occur, especially in people with sensitive skin.

Individuals concerned about the potential risks of talc-containing products should consider alternatives. As with any substance, moderation and careful use are advisable, and individuals experiencing adverse effects should seek medical advice.

​Titanium dioxide is a widely used pigment and additive in various products, including cosmetics, sunscreens, paints, and food items. While it is generally recognized as safe when used in approved applications, there are concerns about potential health risks associated with certain forms and uses of titanium dioxide. Here are some considerations:

1. Genotoxicity Concerns: Most relevant to the consumption of Wellbutrin, ome studies have suggested that certain forms of titanium dioxide nanoparticles may exhibit genotoxic effects, indicating potential damage to DNA. However, more research is needed to determine the relevance of these findings to human health and to establish safe exposure levels.
2. Potential for Nanoparticle Absorption: Titanium dioxide nanoparticles have raised concerns regarding their potential to penetrate the skin. While research is ongoing, the skin barrier generally prevents the absorption of larger particles. However, nanoparticles may raise questions about their long-term safety, and more studies are needed to understand their effects thoroughly.
   
3. Inhalation Risk (Unlikely a risk with Wellbutrin): Fine particles of titanium dioxide, particularly in the form of nanoparticles, can pose a respiratory risk when inhaled. Occupational exposure in industries such as manufacturing or handling titanium dioxide dust may be associated with respiratory irritation. However, consumer products like sunscreens or cosmetics typically use larger particles that are less likely to be inhaled.

It's important to note that regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA), have assessed the safety of titanium dioxide in approved uses. The permissible limits and specifications vary depending on the application.

Consumers concerned about titanium dioxide can choose products with alternatives or consult with healthcare professionals. As research continues, regulatory agencies may update guidelines to ensure the safe use of titanium dioxide in various products.

It's crucial to recognize that the conditions for which Wellbutrin is prescribed—ADHD, anxiety, obesity, and bipolar disorder—may not be caused by a deficiency of Wellbutrin itself. Rather, these conditions are complex and multifaceted, often influenced by underlying nutrition and lifestyle factors. Addressing these root causes is fundamental to comprehensive and sustainable mental health care.

Depression, a complex and pervasive mental health condition, often finds its roots in a myriad of factors, extending beyond the realm of neurochemistry to include nutrition and lifestyle elements. Understanding and addressing these underlying factors can play a pivotal role in comprehensive depression management. Here's a closer look at the nutrition and lifestyle aspects that contribute to this intricate mental health landscape:
1. Dietary Choices:

• Nutrient Deficiencies: Inadequate intake of essential nutrients, such as omega-3 fatty acids, vitamin D, B-vitamins, and minerals like zinc and magnesium, has been linked to an increased risk of depression. A diet rich in whole foods and diverse nutrients contributes to optimal brain function and mood regulation.

2. Gut-Brain Connection:

• Microbiome Health: The gut-brain axis underscores the bidirectional communication between the gut and the brain. An imbalance in gut microbiota, often stemming from poor dietary habits and antibiotic use, may contribute to inflammation and impact mental health. Probiotics and a fiber-rich diet can foster a healthy gut environment.

3. Blood Sugar Regulation:

• Stable Blood Sugar Levels: Fluctuations in blood sugar levels can affect mood and energy levels. Consuming a balanced diet with complex carbohydrates, fiber, and adequate protein helps regulate blood sugar and prevents energy crashes that may contribute to depressive symptoms.

4. Physical Activity:

• Exercise Benefits: Regular physical activity has been consistently associated with improved mood and reduced depressive symptoms. Exercise promotes the release of endorphins, neurotransmitters that act as natural mood lifters. Incorporating movement into daily routines is a valuable component of depression management.

5. Sleep Hygiene:

• Quality Sleep: Disrupted sleep patterns and insomnia are common features of depression. Prioritizing good sleep hygiene, including consistent sleep schedules, a comfortable sleep environment, and limiting screen time before bed, fosters better sleep quality and supports mental well-being.

6. Stress Management:

• Mind-Body Practices: Chronic stress is a significant contributor to depression. Mindfulness techniques, meditation, yoga, and other stress-reduction practices play a crucial role in managing and preventing depressive symptoms by promoting relaxation and emotional resilience.

7. Social Connections:

• Supportive Relationships: Social isolation and a lack of meaningful connections can contribute to depressive feelings. Nurturing positive relationships and maintaining a strong social support system are integral to emotional well-being.

Recognizing the impact of these nutrition and lifestyle factors on depression emphasizes the importance of a holistic approach to mental health. Integrating dietary changes, exercise, sleep hygiene, stress reduction, and social engagement into depression management plans provides individuals with a comprehensive toolkit for fostering mental well-being. As with any health concern, consultation with healthcare professionals is crucial to tailor interventions to individual needs and circumstances.

As with many psychotropic medications, Wellbutrin (bupropion) requires careful consideration when discontinuing to minimize the risk of withdrawal symptoms. Abruptly stopping Wellbutrin, also known as going "cold turkey," can lead to uncomfortable and potentially distressing withdrawal symptoms. It is crucial to approach the discontinuation of Wellbutrin with a gradual tapering process, personalized to individual needs, to ensure a smoother transition.

Withdrawal symptoms, often associated with sudden cessation of psychotropic drugs, can manifest as a range of physical and psychological discomforts. These may include dizziness, headaches, irritability, mood swings, insomnia, and flu-like symptoms. The severity and duration of withdrawal symptoms can vary from person to person.

To mitigate the risk of withdrawal symptoms, the American Psychiatric Association recommends a tapering approach for all antidepressants, including Wellbutrin. Tapering involves gradually reducing the dosage over a specified period, allowing the body to adjust to the decreasing levels of the medication.

It is paramount not to discontinue Wellbutrin without consulting your healthcare provider. Your doctor can create a personalized taper schedule based on factors such as the duration of your medication use, your current dosage, and any specific symptoms you may be experiencing. Tapering is typically done over 6 to 8 weeks to provide a gradual adjustment.

Every individual responds differently to medication changes. Your doctor can tailor the taper schedule to your unique needs, ensuring a careful balance between minimizing withdrawal symptoms and maintaining mental health stability.

If you begin to experience withdrawal symptoms during the tapering process, it is crucial to communicate promptly with your healthcare provider. They may need to reassess your taper schedule or make adjustments based on your symptoms. Restarting Wellbutrin can often alleviate withdrawal symptoms within a few days.

The journey of tapering off Wellbutrin is a collaborative effort between you and your healthcare provider. Open communication about your experiences and any emerging symptoms allows for adjustments that prioritize your well-being throughout the process.

In the realm of psychotropic medications, a thoughtful and gradual approach to discontinuation is key. Tapering off Wellbutrin under the guidance of your healthcare provider not only minimizes the risk of withdrawal symptoms but also ensures a smoother transition, prioritizing your mental health. Remember, your doctor is your ally in this process, and together, you can navigate the complexities of tapering to promote your overall well-being.

“Bupropion - Drug Usage Statistics, ClinCalc DrugStats Database.” Clincalc.com, 2021, clincalc.com/DrugStats/Drugs/Bupropion. Medical Expenditure Panel Survey (MEPS) 2013-2021. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 2024.01.

“Wellbutrin: Package Insert / Prescribing Information.” Drugs.com, www.drugs.com/pro/wellbutrin.html.

​Starr P, Klein-Schwartz W, Spiller H, Kern P, Ekleberry SE, Kunkel S. Incidence and onset of delayed seizures after overdoses of extended-release bupropion. Am J Emerg Med. 2009 Oct;27(8):911-5. doi: 10.1016/j.ajem.2008.07.004. PMID: 19857406.

​Spiller, Henry A., et al. “Bupropion Overdose: A 3-Year Multi-Center Retrospective Analysis.” The American Journal of Emergency Medicine, vol. 12, no. 1, Jan. 1994, pp. 43–45, https://doi.org/10.1016/0735-6757(94)90195-3. Accessed 28 Nov. 2021.

Bakthavachalu, Prabasheela, et al. “Food Color and Autism: A Meta-Analysis.” Advances in Neurobiology, vol. 24, 2020, pp. 481–504, pubmed.ncbi.nlm.nih.gov/32006369/#:~:text=Many%20families%20with%20autistic%20children, https://doi.org/10.1007/978-3-030-30402-7_15.

Hussain, Sunny Z., et al. “Probable Neuropsychiatric Toxicity of Polyethylene Glycol: Roles of Media, Internet and the Caregivers.” GastroHep, vol. 1, no. 3, May 2019, pp. 118–123, https://doi.org/10.1002/ygh2.336. 

Sellaturay, Priya, et al. “Polyethylene Glycol–Induced Systemic Allergic Reactions (Anaphylaxis).” The Journal of Allergy and Clinical Immunology: In Practice, Oct. 2020, https://doi.org/10.1016/j.jaip.2020.09.029.

“Drugs & Medications.” Webmd.com, 2019, www.webmd.com/drugs/2/drug-17118/polyethylene-glycol-3350-oral/details.

​Black RE, Hurley FJ, and Havery DC. “Occurrence of 1,4-dioxane in cosmetic raw materials and finished cosmetic products.” Int J PharJ AOAC Int. 84, 3 (May-Jun 2001):666-70.

Brashear, A. et al. “Ethylene oxide neurotoxicity: a cluster of 12 nurses with peripheral and central nervous system toxicity.” Neurology 46, 4 (Apr 1996):992-8.

California. EPA. Office of Environmental Health Hazard Assessment. Chemicals Known to the State to Cause Cancer or Reproductive Toxicity. February 5, 2010.https://www.oehha.org/prop65/prop65_list/files/P65single020510.pdf

Environmental Health Association of Nova Scotia. Guide to Less Toxic Products.Halifax: EHANS, 2004. https://www.lesstoxicguide.ca/index.asp?fetch=personal#commo.

OCA (Organic Consumer Association). 2008. Consumer alert. Cancer-causing 1,4-dioxane found in personal care products misleadingly branded as natural and organic. Available: https://www.organicconsumers.org/bodycare/DioxaneRelease08.cfm

Wangenheim J and Bolcsfoldi G. “Mouse lymphoma L5178Y thymidine kinase locus assay of 50 compounds.” Mutagenesis 3, 3 (May 1988):193-205.

Biondi O, Motta S, and Mosesso P. “Low molecular weight polyethylene glycol induces chromosome aberrations in Chinese hamster cells cultured in vitro.” _Mutagenesis_17, 3 (May 2002):261-4.

Lanigan, RS (CIR Expert Panel). “Final report on the safety assessment of PPG-11 and PPG-15 stearyl ethers.” Int J Toxicol.20 Suppl 4 (2001):13-26

Cosmetic Ingredient Review. Ingredient Reports — Quick Reference Table (summarizing publications through Dec 2009). https://www.cir-safety.org/staff_files/PublicationsListDec2009.pdf

Epstein, S with Fitzgerald, R. Toxic Beauty. Dallas: BenBella Books, 2009: 158-9.

Chen, Tao , et al. “Genotoxicity of Titanium Dioxide Nanoparticles.” Journal of Food and Drug Analysis, vol. 22, no. 1, 1 Mar. 2014, pp. 95–104, https://www.sciencedirect.com/science/article/pii/S102194981400009X, https://doi.org/10.1016/j.jfda.2014.01.008.

Notice this "U" shape in the curve when examining the relationship between RT and morbidity and mortality. This curve suggests that some RT is clearly beneficial, but has the volume of RT increases past a certain point the benefits drop and it becomes harmful. The concept of a "biphasic response" is fundamental to understanding hormesis. It describes the characteristic dose-response relationship observed in hormetic processes, where a substance or stressor elicits opposite effects at low and high doses. The response can be visualized as a U-shaped or J-shaped curve, illustrating the beneficial effects at low doses and potential harm at higher doses. ​

Paluch, Amanda E, et al. “Resistance Exercise Training in Individuals with and without Cardiovascular Disease: 2023 Update: A Scientific Statement from the American Heart Association.” Circulation, 7 Dec. 2023, https://doi.org/10.1161/cir.0000000000001189. Accessed 11 Dec. 2023.

Momma H, Kawakami R, Honda T, Sawada SS. Muscle-strengthening activities are associated with lower risk and mortality in major non-communicable diseases: a systematic review and meta-analysis of cohort studies. Br J Sports Med. 2022 Jul;56(13):755-763. doi: 10.1136/bjsports-2021-105061. Epub 2022 Feb 28. PMID: 35228201; PMCID: PMC9209691.

The leading cause of death in the United States is cardiovascular disease, and the risk of cardiovascular issues can be predicted by factors such as blood pressure, heart rate variability, blood pressure variability, and cardiac vagal baroreflex sensitivity. The interplay between the cardiovascular and respiratory systems is highlighted, with a particular emphasis on how respiration affects key prognostic cardiovascular variables.

This study explores the impact of nasal breathing compared to oral breathing on cardiovascular health in young adults. Nasal breathing is associated with humidification, warming, and filtration of inhaled air, potentially leading to bronchodilation and improved breathing efficiency. While past research has shown nasal breathing to have positive effects on resting metabolic demands, its influence on cardiovascular markers is not well-understood.

The primary hypothesis is that nasal breathing, as opposed to oral breathing, will result in decreased blood pressure, improved heart rate variability, reduced blood pressure variability, and increased cardiac vagal baroreflex sensitivity at rest. The study aims to contribute to the understanding of how breathing patterns influence prognostic cardiovascular variables, aligning with the broader interest in the impact of breathing pace and training on cardiovascular health.

The secondary hypothesis focuses on the effects of nasal breathing during submaximal exercise. The expectation is that nasal breathing, by attenuating the ventilatory response and metabolic demands, will lead to reduced blood pressure responses, improved heart rate variability, and decreased blood pressure variability during exercise. This aspect is particularly relevant due to the association between elevated exercise blood pressure and the risk of developing hypertension and cardiovascular disease.

The study findings are summarized, focusing on the impact of nasal vs. oral breathing on physiological and subjective variables at rest and during exercise. At rest, nasal breathing is associated with lower mean and diastolic blood pressure, improved heart rate variability metrics, reduced LF/HF ratio, and lower ratings of perceived exertion (RPE) and breathlessness (RPB). However, it increased systolic blood pressure average real variability. During submaximal exercise, differences between nasal and oral breathing were observed for RPB, suggesting a modest effect on reducing breathlessness during acute exercise.

The discussion delves into the potential clinical significance of these findings, particularly the reduction in diastolic blood pressure during nasal breathing at rest. The study suggests a greater parasympathetic to sympathetic dominance during nasal breathing, indicated by changes in frequency-domain metrics of heart rate variability. Although nasal breathing did not significantly affect beat-to-beat blood pressure variability, there is speculation about potential connections between respiratory variables and blood pressure changes, emphasizing the need for further investigation.

The study notes that the impact of nasal breathing on cardiovascular variables may have implications for various populations and suggests avenues for future research, including examining nasal breathing's effects on blood pressure over longer durations, both at rest and during activities like exercise. The discussion also touches on the potential benefits of interventions like mouth-taping overnight, emphasizing the importance of considering nasal breathing in the context of broader health outcomes.

Watso, Joseph C., et al. “Acute Nasal Breathing Lowers Diastolic Blood Pressure and Increases Parasympathetic Contributions to Heart Rate Variability in Young Adults.” American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, vol. 325, no. 6, 1 Dec. 2023, pp. R797–R808, pubmed.ncbi.nlm.nih.gov/37867476/, https://doi.org/10.1152/ajpregu.00148.2023.